AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

AstraZeneca Plc’s Chief Executive Officer Pascal Soriot warned that trade tariffs are not the best way to manage ...

Pascal Soriot (pictured) said innovation in pharma 'has mostly been funded by the US' as he doubled down on plans to grow the ...

AstraZeneca (AZN) reported mixed first quarter earnings results, missing on revenue estimates but beating on earnings per ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

So that would be a huge incentive to also bring manufacturing here," Bourla said. His comments mirror those of AstraZeneca ...

AstraZeneca has warned that countries must buy more of its cutting-edge medicines or jobs and investment will shift abroad.

AstraZeneca has come up short in another phase 3 trial of the AKT inhibitor Truqap, raising more questions about the ...

"Our company is firmly committed to investing and growing in the US," chief executive Pascal Soriot said in an earnings ...

AZ has already thrown down a marker for its tougher stance on Europe, with an earlier decision to abandon a $560 million ...